Could Beckman Coulter’s Access p-Tau217 test make Alzheimer’s diagnosis faster and cheaper?
Beckman Coulter Diagnostics has secured European clearance for its automated Access p-Tau217 blood test, potentially widening access to Alzheimer’s biomarker testing while raising questions about reimbursement, intermediate results and clinical interpretation.
